Back
Revance Therapeutics Vs. Cassava Sciences Industry Stock Comparison
Sell
10
RVNC
Revance Therapeutics
Last Price:
3.73
Seasonality Move:
2.15%
Buy
63
SAVA
Cassava Sciences
Last Price:
26.49
Seasonality Move:
47.33%
Sell
10
Revance Therapeutics (RVNC)
is a Sell
Is Revance Therapeutics a Buy, Sell or Hold?
- The current Revance Therapeutics [RVNC] share price is $3.84. The Score for RVNC is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
- RVNC is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
63
Cassava Sciences (SAVA)
is a Buy
Is Cassava Sciences a Buy, Sell or Hold?
- The current Cassava Sciences [SAVA] share price is $32.18. The Score for SAVA is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- SAVA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RVNC Stock Price Chart
What is Revance Therapeutics's stock price today?
-
The Revance Therapeutics share price today is $3.84
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RVNC is experiencing slight buying pressure.
SAVA Stock Price Chart
What is Cassava Sciences's stock price today?
-
The Cassava Sciences share price today is $32.18
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SAVA is experiencing buying pressure, which is a positive indicator for future bullish movement.
RVNC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.44 | Sell |
| Relative Strength Index (14 RSI): | 34.28 | Sell |
| Chaikin Money Flow: | 227722 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.06 - 5.8) | Sell |
| Bollinger Bands (100): | (3.74 - 6.28) | Sell |
SAVA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.36 | Buy |
| Relative Strength Index (14 RSI): | 64.8 | Buy |
| Chaikin Money Flow: | 2523870 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.39 - 28.53) | Buy |
| Bollinger Bands (100): | (17.94 - 31.2) | Buy |
RVNC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.03 | Sell |
| 20-day SMA: | 4.84 | Sell |
| 50-day SMA: | 5.22 | Sell |
| 200-day SMA: | 4.61 | Sell |
| 8-day EMA: | 4.07 | Sell |
| 20-day EMA: | 4.56 | Sell |
| 50-day EMA: | 4.97 | Sell |
| 200-day EMA: | 6.03 | Sell |
SAVA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.35 | Buy |
| 20-day SMA: | 26.62 | Buy |
| 50-day SMA: | 27.56 | Buy |
| 200-day SMA: | 22.93 | Buy |
| 8-day EMA: | 27.96 | Buy |
| 20-day EMA: | 27.22 | Buy |
| 50-day EMA: | 26.84 | Buy |
| 200-day EMA: | 24.22 | Buy |
Revance Therapeutics Earnings Growth & RVNC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.51 per share, and an increase next year of $0.58 per share.
Cassava Sciences Earnings Growth & SAVA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.98 per share, and an increase next year of $0.59 per share.
Revance Therapeutics Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Cassava Sciences Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||